National Association of Testing Authorities, Australia
Scope of Accreditation
QML Pathology
Site
Brisbane Laboratory – Healius Pathology Pty Ltd
Accreditation No.
2184
Site No.
2177
Date of Accreditation
30 Apr 1987
Address
11 Riverview Place, Rooms G-02 – G-10 Ground Floor and First Floor, Metroplex on Gateway
Murarrie, QLD 4172
Australia
Contact
Ms Fiona Phillips P: +61 (07) 31214980
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Chemical Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Oct 2026
Last Activity Date
08 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of calculus | Renal calculi | Ammonium; Bilirubin; Calcium; Carbonate; Cholesterol; Cysteine; Magnesium; Oxalate; Phosphate; Urate |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Serum | Alcohol |
| Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders | Serum | Carbohydrate deficient transferrin |
| Chemical pathology - Biogenic amines | Blood | Histamine |
| Plasma | 3-Methoxytyramine; Metanephrine; Normetanephrine | |
| Urine | 3-Methoxytyramine; 5-Hydroxyindoleacetic acid (5-HIAA); Adrenaline; Dopamine; Homovanillic acid (HVA); Metanephrine; Noradrenaline; Normetanephrine; Vanillylmandelic acid (VMA) | |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Tacrolimus |
| Serum | Amiodarone; Flecainide | |
| Lithium | ||
| Amitriptyline; Clobazam; Clomipramine; Clonazepam; Desipramine; Diazepam; Dothiepin (dosulepin); Doxepin; Flunitrazepam; Imipramine; Lamotrigine; Levetiracetam; Nitrazepam; Norclomipramine; Nordoxepin; Nortriptyline; Oxazepam; Perhexiline; Sulthiame; Trimipramine | ||
| Carbamazepine; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Methotrexate; Phenobarbital; Phenytoin (dilantin); Theophylline; Tobramycin; Valproate (valproic acid, epilim); Vancomycin | ||
| Clozapine | ||
| Paracetamol (acetaminophen); Salicylate | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Serum | Soluble mesothelin related peptides (SMRP) |
| Human chorionic gonadotropin (hCG) | ||
| β2-Microglobulin (B2M) | ||
| Chromogranin A - Gen I | ||
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA) | ||
| Prostate specific antigen (PSA); Prostate specific antigen (PSA) fractions and derived index | ||
| Human epididymal protein 4 | ||
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Renin |
| Copeptin | ||
| Serum | Androstenedione; Gastrin; Growth hormone | |
| 17α-Hydroxyprogesterone | ||
| C-peptide; Dehydroepiandrosterone (DHEA); Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone; Testosterone - Free | ||
| Anti-Mullerian hormone (AMH) | ||
| Aldosterone | ||
| Calcitonin; Insulin-like growth factor 1 (IGF-1, somatomedin C) | ||
| Serum; Urine | Aldosterone | |
| Cortisol | ||
| Chemical pathology - Diagnosis and management of diabetes mellitus | Serum | Fructosamine |
| Chemical pathology - Further investigation of cardiac function | Serum | Troponin T |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Serum | HDL - Quantitation; Lipoprotein subclasses |
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Caeruloplasmin; Haptoglobins |
| Alkaline phosphatase (ALP) isoenzymes; Lactate dehydrogenase (LDH) isoenzymes | ||
| α1-Antitrypsin | ||
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
| Serum | Myoglobin | |
| Urine | Bilirubin; Pigments in fluids | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Albumin; Chloride; Glucose; Lactate; Protein - Total |
| Plasma | Lactate | |
| Plasma; Serum | Ammonia; Cholinesterase | |
| Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; Calcium - Total; Chloride; Cholesterol - Total; Cholinesterase; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Pseudocholinesterase; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Angiotensin converting enzyme (ACE); Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - LDL; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; HDL - Quantitation; High sensitivity C-reactive protein (CRP); Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | ||
| Calcium - Ionised | ||
| C1 esterase inhibitor | ||
| Serum; Urine | Osmolality | |
| Urine | Amylase; Calcium - Total; Chloride; Creatinine; Magnesium; Microalbumin; Phosphorus; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for foetal lung maturity and/or foetal abnormalities | Serum | Placental growth factor (PGF, PLGF) |
| Chemical pathology - Investigation for folate deficiency | Blood | Folate |
| Chemical pathology - Investigation of Helicobacter pylori colonisation or eradication | Breath | C14 |
| Chemical pathology - Investigation of malabsorption | Breath | Breath hydrogen |
| Faeces | Faecal fat | |
| Faeces; Urine | Sugar seperation analysis | |
| Reducing substances | ||
| Chemical pathology - Investigation of malabsorption - Quantitation of solid tissue enzymes | Intestinal tissue | Alkaline phosphatase; Lactase; Maltase; Protein - Microsomal triglyceride transfer (MTP); Sucrase |
| Chemical pathology - Investigation of maternal markers to detect foetal abnormality | Amniotic fluid; Serum | α-Fetoprotein (AFP) |
| Serum | Free β-human chorionic gonadotropin (free β-hCG); Human chorionic gonadotropin (hCG) - Total; Oestriol - Unconjugated; Pregnancy associated plasma protein A (PAPP-A); α-Fetoprotein (AFP) | |
| Chemical pathology - Investigation of porphyria | Blood; Urine | Porphobilinogen (PBG); Porphyrins - Total; Protoporphyrin; Uroporphyrin; Zinc protoporphyrin (ZPP) |
| Chemical pathology - Iron studies | Serum | Ferritin; Iron; Total iron-binding capacity (TIBC); Transferrin |
| Chemical pathology - Markers of bone metabolism | Serum | Bone-specific alkaline phosphatase - Ostase |
| Urine | Deoxypyridinoline (DPD) | |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Methaemoglobin (MetHb); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); pH |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Serum | Homocysteine |
| Chemical pathology - Quantitation of vitamin B markers | Serum | Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Quantitation of vitamins | Blood | Pyridoxine (vitamin B6, pyridoxal, pyridoxamine); Thiamine (vitamin B1) |
| Riboflavin (vitamin B2) | ||
| Cobalamin (vitamin B12) | ||
| Plasma | Vitamin K | |
| Serum | Vitamin D | |
| Ascorbic acid (vitamin C) | ||
| Carotenoids | ||
| Retinol (vitamin A); Tocopherol (vitamin E) | ||
| Chemical pathology - Tests for thyroid function | Serum | Triiodothyronine (T3) - Reverse |
| Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free | ||
| Chemical pathology - Trace element analysis | Blood | Lead |
| Serum | Copper | |
| Zinc | ||
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-thyroid stimulation immunoglobulin antibodies (TSI) |
| Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) | ||
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cerebrospinal fluid (CSF) | γ-Globulin |
| Plasma; Serum | Cryofibrinogen | |
| Serum | Characterisation of paraproteins; Detection and amount of paraproteins; Detection and quantitation of free kappa and free lambda light chains; Detection of Bence Jones proteins; Protein classes | |
| Urine | Characterisation of paraproteins; Detection and amount of paraproteins; Detection and quantitation of free kappa and free lambda light chains; Detection of Bence Jones proteins; Protein classes | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Immunoglobulin subclasses; Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Immunopathology - Tests of cellular immunity - Cytokine assays | Serum | Interleukin 6 |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Urine | Human chorionic gonadotropin (hCG) |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | Fructose |
Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Oct 2026
Last Activity Date
08 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Lysozyme |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Diagnosis of thalassemia | Blood | Examination of haemoglobin H (HbH); Haemoglobin A (HbA) - Quantitation; Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation |
| Haematology - Examination of blood films by special staining | Blood | Heinz bodies; Neutrophil alkaline phosphatase (NAP) score |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Feto-maternal haemorrhage (FMH) estimation; Presence of foetal red blood cells |
| Detection and quantitation of foetal red cell antigens; Presence of foetal red blood cells | ||
| Haematology - Full blood examination | Blood | Differential number; Morphology; Reticulocytes |
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Mean corpuscular haemoglobin (MCH); Mean corpuscular haemoglobin concentration (MCHC); Mean corpuscular volume (MCV); Platelet count; Red blood cell distribution width (RDW); Reticulocytes | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet function (PFA) |
| Platelet aggregation | ||
| Plasma | Echis test | |
| Activated partial thromboplastin time (APTT); Activated protein C (APC) resistance; Anti-Xa - Apixaban; Anti-Xa - Rivaroxaban; Anti-Xa activity - Clexane - Low molecular weight heparin; Anti-Xa activity - Fragmin - Low molecular weight heparin; Anti-Xa activity - Heparin activity; Anti-Xa activity - Unfractionated heparin; Anti-thrombin III; D-dimer; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor VIII inhibitor; Factor X; Factor XI; Factor XII; Factor XIII; Fibrinogen; Heparin induced thrombocytopenia (HIT) - Confirmatory; International normalised ratio (INR); Plasminogen; Protein C and protein S; Prothrombin time (PT); Reptilase time; Thrombin time (TT); Von Willebrand factor (vWF); Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation | ||
| Von Willebrand collagen binding assay | ||
| Lupus anticoagulant | ||
| Serum | Heparin induced thrombotic thrombocytopenia (HITT) | |
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin S (HbS) - Presence; Haemoglobin instability |
| Haematology - Investigation of haemolysis | Blood | Haemosiderin; Plasma haemoglobin |
| Hereditary spherocytosis; Paroxysmal nocturnal haemoglobinuria (PNH) screen | ||
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | 7-Aminoactinomycin (7-AAD); Assessment of lymphoid cell populations; CD10; CD103; CD117; CD11b; CD11c; CD123; CD13; CD138; CD14; CD15; CD16; CD18; CD19; CD1a; CD2; CD20; CD200; CD22; CD23; CD235a; CD24; CD25; CD3; CD30; CD33; CD34; CD38; CD4; CD41; CD43; CD45; CD5; CD56; CD57; CD59; CD61; CD64; CD7; CD71; CD79a; CD79b; CD8; CD9; FMC7; HLA-DR antigen; Immunoglobulin A (IgA) specific for α-chains; Immunoglobulin G (IgG); Immunoglobulin M (IgM); Kappa light chains; Lambda light chains; Myeloperoxidase; T-cell receptor γδ (TCRgd); Terminal deoxynucleotidyl transferase (TdT) |
| Immunopathology - Investigation and/or assessment of neutrophils - Functional tests | Blood | Phagocytosis; Quantitative assessment of oxidative pathways |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood; Serum | Infectious mononucleosis |
Histopathology/Cytopathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Oct 2026
Last Activity Date
08 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Cervical smear; Liquid based cytology specimens from cervix | Cytological examination; Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Liquid based cytology specimens | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Aspirates; Bronchial lavage; Cerebrospinal fluid (CSF); Ocular specimens; Other body fluids; Pericardial fluid; Sputum; Synovial fluid; Tumour tissue; Urine; Vitreous specimens; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Anus smears; Conjunctival smears; Lip smears; Mouth smears; Nipple discharge; Nose smears; Semen; Skin smears | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Rapid onsite evaluation (ROSE); Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Cytopathology - Testing for the National Cervical Screening Program | Liquid based cytology specimens from cervix | Human papilloma virus (HPV) |
| Self-collected vaginal swabs | Human papilloma virus (HPV) | |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities; Structured reporting |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in-situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Frozen tissue | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
Immunopathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Oct 2026
Last Activity Date
08 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Tryptase |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Cerebrospinal fluid (CSF) | Anti-neuronal antibodies |
| Serum | Anti-cyclic citrullinated peptide antibodies (CCP) | |
| Anti-deamidated gliadin peptide (DGP) antibodies | ||
| Anti-glomerular basement membrane antibodies (anti-GBM) | ||
| Anti-intrinsic factor antibodies (IF) | ||
| Anti-skeletal muscle antibodies | ||
| Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-pemphigus antibodies; Anti-skin antibodies | ||
| Anti-extractable nuclear antigen antibodies (ENA); Anti-myositis antibodies; Anti-neuronal antibodies; Anti-scleroderma antibodies | ||
| Anti-cardiolipin antibodies (ACA); Anti-β2-glycoprotein-I antibodies | ||
| Anti-adrenal cortex antibodies; Anti-ovarian antibodies (AOA); Anti-testis antibodies | ||
| Anti-myeloperoxidase antibodies (MPO); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-proteinase 3 antibodies (PR3) | ||
| Anti-Saccharomyces cerevisiae antibodies (ASCA); Anti-extractable nuclear antigen antibodies (ENA) | ||
| Anti-glutamic acid decarboxylase antibodies (GAD); Anti-islet cell antigen 2 antibodies | ||
| Anti-endomysial antibodies (EMA); Anti-gastric parietal cell antibodies (GPC/PCA); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-smooth muscle antibodies (SMA) | ||
| Anti-nuclear antibodies (ANA) | ||
| Anti-acetylcholine receptor antibodies (AChR); Anti-double stranded DNA antibodies (dsDNA) | ||
| Anti-tissue transglutaminase antibodies (tTG) | ||
| Anti-deamidated gliadin IgG antibodies; Anti-deamidated gliadin antibodies | ||
| Rheumatoid factor | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing (purified native and/or recombinant allergens)) | Serum | Api m1 phospholipase A2 - Honey bee; Ara h2 - Peanut; Ara h9 - Peanut; Casein - Milk; Cyp - Parvalbumin; Galactose-α-1,3-galactose thyroglobulin - Bovine; Hev b5 - Latex; MUXF3 CCD; Omega-5-gliadin - Wheat; Ovomucoid - Egg; Pol d5 - European paper wasp; Profilin - Peach; Tropomyosin - Shrimp; Ves v5 - Common wasp; α-Lactalbumin - Milk; β-Lactoglobulin - Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Amoxicilloyl group; Ampicilloyl group; Cefaclor; Chlorhexidine; Morphine; Penicilloyl G; Penicilloyl V; Pholcodine; Suxamethonium (succinylcholine) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Animal mix; Budgerigar feathers; Caged bird mix; Cat dander; Chicken feathers; Cow dander; Dog dander; Duck feathers; Guinea pig epithelium; Horse dander; Mouse epithelium; Mouse serum proteins; Mouse urine proteins; Rat epithelium; Rat serum proteins; Rat urine proteins; Sheep epithelium |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [additives] allergens) | Serum | Cochineal extract (carmine red, E120); Gum arabic (E414) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Chicken; Egg white; Egg yolk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Anchovy; Blue mussel; Codfish; Crab; Hake; Lobster; Oyster; Salmon; Scallop; Seafood mix; Shrimp; Squid; Tuna |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Apple; Aubergine (eggplant); Avocado; Banana; Blueberry; Capsicum; Citrus mix; Fruit mix; Garlic; Grape; Kiwi; Mango; Melon; Onion; Orange citrus; Peach; Pineapple; Potato; Raspberry; Strawberry; Tomato; Vegetable mix; Watermelon |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Meat mix; Mutton; Pork |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Cheese - Cheddar type; Goat milk; Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Cacao; Coffee; Honey; Mushroom; Yeasts |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Barley; Brazil nut; Buck wheat; Cashew nut; Cereal mix; Coconut; Corn; Gluten; Hazelnut; Lupin seed; Macadamia nut; Maize; Nut panel; Oat; Peanut; Pecan nut; Pinenut; Pistachio; Rice; Rye; Sesame seed; Soy bean; Walnut; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bahia grass; Bermuda grass; Couch grass; Cultivated wheat; Grass mix; Johnson grass; Kentucky blue; Meadow grass; Rye grass; Timothy grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | Fire ant; German cockroach; Mosquito |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria alternata; Anisakis; Aspergillus fumigatus; Botrytis cinerea; Candida albicans; Cladosporium herbarum; Malassezia spp.; Mucor racemosus; Penicillium chrysogenum (formerly Penicillium notatum); Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Acarus siro storage mite; Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite; House dust - Hollister-Stier; House dust mite mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Disinfectants mix; Latex; Maxatase; Reactant chemicals mix; Savinase; Sunflower seed; α-Amylase |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Acacia; Australian pine; Eucalyptus; Melaleuca; Olive; Privet; Queen palm; Silver birch; Tree mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Common wasp (yellow jacket) venom; Common wasp allergen component; European paper wasp venom; Honey bee venom; Paper wasp venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Common ragweed; Marguerite; Ox-eye daisy; Plantain - English; Ribwort; Weed mix; Western ragweed |
| Immunopathology - Quantitation of complement proteins | Serum | Total haemolytic complement |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin; Pancreatic elastase |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin E |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Faeces | Helicobacter pylori antigen |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Aspirates; Bronchial washings; Bronchoalveolar lavage; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs | Bordetella pertussis |
| Bronchoalveolar lavage | Chlamydophila pneumoniae; Legionella spp.; Mycoplasma pneumoniae | |
| Cerebrospinal fluid (CSF); Plasma | Neisseria meningitidis; Streptococcus pneumoniae | |
| Faeces | Aeromonas spp.; Campylobacter spp.; Salmonella spp.; Shigella spp.; Yersinia enterocolitica | |
| Genital swabs; Rectal swabs; Throat swabs; Urine | Neisseria gonorrhoeae | |
| Chlamydia trachomatis | ||
| Genital swabs; Urine | Mycoplasma genitalium | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Bronchoalveolar lavage | Pneumocystis jirovecii |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Blastocystis spp.; Cryptosporidium spp.; Dientamoeba spp.; Entamoeba histolytica; Giardia spp. |
| Genital swabs; Urine | Trichomonas vaginalis | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Aspirates; Bronchial washings; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Throat swabs | Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV) A/B; Rhinovirus |
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | ||
| Cerebrospinal fluid (CSF); General swabs | Adenovirus; Enterovirus; Herpes simplex virus (HSV); Human parechovirus; Varicella zoster virus (VZV) | |
| Cervical specimen; Liquid based cytology specimens | Human papilloma virus (HPV) | |
| Plasma | Cytomegalovirus (CMV) | |
| Human immunodeficiency virus type 1 (HIV-1) RNA | ||
| Plasma; Serum | Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA | |
| Serum | Hepatitis C virus (HCV) genotypes 1-6 and subtypes | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Chlamydial spp. IgG antibody |
| Schistosoma mansoni IgG antibody | ||
| Hepatitis D virus antibody (anti-HDV) | ||
| Streptococcal anti-DNAse B (anti-streptodornase) antibody; Anti-streptolysin O (ASOT) | ||
| Strongyloides IgG antibody | ||
| Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis A virus antibody (anti-HAV) - Total; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Rubella IgG antibody; Rubella IgM antibody; Syphilis Treponema pallidum antibody; Toxoplasma spp. IgG antibody; Toxoplasma spp. IgM antibody | ||
| Cytomegalovirus (CMV) IgG avidity; Cytomegalovirus antibody (anti-CMV) IgM; Rubella IgM antibody; Toxoplasma spp. IgM antibody | ||
| Barmah forest virus IgG antibody; Barmah forest virus IgM antibody; Brucella spp.; Dengue virus IgG antibody; Dengue virus IgM antibody; Leptospira IgM antibody; Ross River virus IgG antibody; Ross River virus IgM antibody | ||
| Coxiella burnetii (Q-fever) IgA phase 1 antibody; Coxiella burnetii (Q-fever) IgA phase 2 antibody; Coxiella burnetii (Q-fever) IgG phase 1 antibody; Coxiella burnetii (Q-fever) IgG phase 2 antibody; Coxiella burnetii (Q-fever) IgM phase 1 antibody; Coxiella burnetii (Q-fever) IgM phase 2 antibody | ||
| Spotted fever IgM antibody | ||
| Bordetella pertussis IgA; Bordetella pertussis IgG; Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Measles IgG antibody; Measles IgM antibody; Mumps virus IgG antibody; Mumps virus IgM antibody; Mycoplasma pneumoniae IgG antibody; Mycoplasma pneumoniae IgM antibody; Parvovirus B19 IgG antibody; Parvovirus B19 IgM antibody; Varicella zoster virus (VZV) IgG antibody; Varicella zoster virus IgM antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Coxiella burnetii (Q-fever) IgA phase 1 antibody; Coxiella burnetii (Q-fever) IgA phase 2 antibody; Coxiella burnetii (Q-fever) IgG phase 1 antibody; Coxiella burnetii (Q-fever) IgG phase 2 antibody; Coxiella burnetii (Q-fever) IgM phase 1 antibody; Coxiella burnetii (Q-fever) IgM phase 2 antibody | ||
| Aspergillus spp. total antibody | ||
| Dengue virus NS1 antigen | ||
| Brucella abortus antibody | ||
| Legionella spp. | ||
| Helicobacter pylori IgG antibody | ||
| Chlamydial spp. IgG antibody; Chlamydial group IgA antibody | ||
| Influenza A virus; Influenza B virus | ||
| Hepatitis E virus (HEV) IgM | ||
| Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis A virus antibody (anti-HAV) - Total; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antigen (HBs Ag); Human immunodeficiency virus (HIV) | ||
| Tetanus | ||
| Bartonella spp. IgG antibody; Bartonella spp. IgM antibody | ||
| Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Epstein-Barr virus nuclear antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgM antibody; Hepatitis C virus (HCV); Human T-lymphotropic virus type I/II (HTLV-I/II) |
Microbiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Oct 2026
Last Activity Date
08 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Infertility and pregnancy tests including assisted reproductive technology - Investigation of sperm | Semen; Serum | Sperm antibodies |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | Vitality |
| Agglutination; Leucocytes (white blood cells, WBC); Morphology; Motility; Sperm number | ||
| Viscosity; Volume | ||
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis for post vasectomy and/or examination of cervical mucus | Semen | Presence of spermatozoa |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fluids; General swabs; Genital swabs; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Operative specimens; Post-operative wounds; Pus; Rectal swabs; Respiratory specimens; Skin; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urethra; Urine; Vaginal swabs; Wound swabs | Streptococcus group B screening; Antibiotic susceptibility; Cultured pathogens identification; Pathogenic identification and antibiotic susceptibility |
| Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Fluids; General swabs; Genital swabs; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Operative specimens; Post-operative wounds; Pus; Rectal swabs; Respiratory specimens; Skin; Sputum; Superficial sites; Synovial fluid; Throat swabs; Vaginal swabs; Wound swabs | Bacteria; Casts; Crystals; Epithelial cells; Leucocytes (white blood cells, WBC); Pathogenic microorganisms | |
| Cerebrospinal fluid (CSF) | Streptococcus pneumoniae | |
| Faeces | Clostridioides difficile toxin | |
| Urine | Casts; Crystals; Epithelial cells; Leucocytes (white blood cells, WBC) | |
| Erythrocytes (red blood cells, RBC); Glucose; Ketones; Leucocytes (white blood cells, WBC); Proteins | ||
| Legionella antigen; Streptococcus pneumoniae | ||
| Microbiology - Environmental investigations and/or infection control | Gastrointestinal endoscopes | Bacterial growth - Sterility |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Faeces | Clostridioides difficile |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Plasmodium falciparum; Plasmodium malariae; Plasmodium ovale curtisi; Plasmodium ovale wallikeri; Plasmodium vivax |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasal swabs; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasal swabs; Nasopharyngeal swabs; Oropharyngeal swabs; Sputum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasopharyngeal swabs; Oropharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Microbiology - Molecular biology - Surveillance programme for the detection of microbial nucleic acids (viruses) in accordance with Commonwealth and/or State Health protocols | Saliva | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Respiratory specimens | Mycobacteria identification; Other pathogenic bacteria to genus level or species level |
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Plasma | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Cerebrospinal fluid (CSF); Nails; Skin; Skin scrapings | Dermatophyte identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen |
| Isolates; Respiratory specimens | Fungi identification; Yeast susceptibility; Yeasts identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cysts; Ova; Parasites |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgM antibody |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgM antibody | ||
| Microbiology - Virology - Detection of pathogenic viruses | Faeces | Adenovirus; Rotavirus |
Toxicology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Oct 2026
Last Activity Date
08 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Urine | 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP); Amphetamine type substances; Barbiturates; Benzodiazepines; Buprenorphine; Cannabinoids; Cocaine metabolites; Ethanol; Ethylglucuronide (ETG); Opiates; Oxycodone |
| 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP); 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; Amphetamines; Anti-psychotic agents; Aripiprazole; Benzoylecgonine (ecgonine benzoate); Buprenorphine; Bupropion; Clozapine; Codeine; Codeine-6-glucuronide (codeine-6-β-D-glucuronide); Dextromethorphan; Dihydrocodeine (6α-hydrocodol); Doxylamine; Ecgonine methyl ester; Fentanyl; Hydrocodone; Hydromorphone; Ketamine; Lurasidone; Lysergic acid diethylamide (LSD, lysergide); Meperidine (pethidine); Mescaline; Methadone; Methamphetamine; Methylphenidate; Mirtazapine; Moclobemide; Modafinil acid; Morphine; Morphine-3-glucuronide (morphine-3-β-D-glucuronide); Naloxone; Naltrexone; O-Desmethyltramadol; Olanzapine; Oxycodone; Paliperidone; Phencyclidine; Phentermine; Pholcodine; Pregabalin; Promethazine; Propofol glucuronide; Propoxyphene; Pseudoephedrine (PSE); Quetiapine; Ranitidine; Remifentanil; Selective serotonin reuptake inhibitor (SSRI) antidepressants; Selegiline; Serotonin norepinephrine reuptake inhibitor (SNRI) antidepressants; Strychnine; Tapentadol; Thebaine; Tramadol; Tricyclics; Zolpidem; Zopiclone | ||
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Urine | Amphetamine type substances; Barbiturates; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Ethanol; Ethylglucuronide (ETG); Opiates; Oxidants |
| 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP); 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); Amisulpride; Amitriptyline; Amphetamines; Aripiprazole; Benzoylecgonine (ecgonine benzoate); Buprenorphine; Buprenorphine-3-β-D-glucuronide; Bupropion; Chlorpromazine; Clomipramine; Codeine; Desipramine; Dextromethorphan; Dothiepin (dosulepin); Doxepin; Doxylamine; Ecgonine methyl ester; Fentanyl; Hydrocodone; Hydromorphone; Imipramine; Ketamine; Lurasidone; Lysergic acid diethylamide (LSD, lysergide); Meperidine (pethidine); Mescaline; Methadone; Methamphetamine; Methylphenidate; Mirtazapine; Moclobemide; Morphine; Morphine-3-glucuronide (morphine-3-β-D-glucuronide); Naloxone; Naltrexone; Nortriptyline; O-Desmethyltramadol; Olanzapine; Oxycodone; Paliperidone; Phencyclidine; Phentermine; Pholcodine; Pregabalin; Promethazine; Propofol; Propoxyphene; Pseudoephedrine (PSE); Quetiapine; Ranitidine; Remifentanil; Selective serotonin reuptake inhibitor (SSRI) antidepressants; Selegiline; Serotonin norepinephrine reuptake inhibitor (SNRI) antidepressants; Tapentadol; Thebaine; Trimipramine; Zolpidem; Zopiclone | ||
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Urine | Creatinine; Specific gravity; Urea; pH |
ISO 15189 (2022)
Legal
Medicare expiry date
01 Oct 2026
Last Activity Date
08 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing | Hair | 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP); 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Alprazolam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Buprenorphine; Clonazepam; Cocaethylene; Cocaine; Codeine; Diazepam; Etizolam; Fentanyl; Flunitrazepam; Hydrocodone; Hydromorphone; Ketamine; Lorazepam; Lysergic acid diethylamide (LSD, lysergide); Meperidine (pethidine); Methadone; Methylamphetamine; Midazolam; Modafinil; Morphine; N-Desmethyltramadol; Nitrazepam; Norbuprenorphine; Nordiazepam; Norfentanyl; Norketamine; Normeperidine; Noroxycodone; Oxazepam; Oxycodone; Phentermine; Pregabalin; Promethazine; Propofol glucuronide; Pseudoephedrine (PSE); Temazepam; Tramadol; Zolpidem; Zopiclone; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
| Medico legal drug testing AS/NZS 4308:2008, section 2 Specimen collection, storage, handling and dispatch | Urine | Colour |
| Creatinine; Temperature; pH | ||
| Medico legal drug testing AS/NZS 4308:2008, section 3 General laboratory requirements | Urine | General laboratory requirements as described in AS/NZS 4308 |
| Medico legal drug testing AS/NZS 4308:2008, section 4 Laboratory screening procedures | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; Opiates; Oxidants; Specific gravity; Urea; pH |
| Medico legal drug testing AS/NZS 4308:2008, section 5 Laboratory confirmatory procedures | Urine | 11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Cocaine; Codeine; Codeine-6-glucuronide (codeine-6-β-D-glucuronide); Diazepam; Ecgonine methyl ester; Ephedrine; Methylamphetamine; Morphine; Morphine-3-glucuronide (morphine-3-β-D-glucuronide); Morphine-6-glucuronide (morphine-6-β-D-glucuronide); Nordiazepam; Oxazepam; Phentermine; Pseudoephedrine (PSE); Salbutamol; Temazepam; Terbutaline; α-Hydroxyalprazolam |
| Medico legal drug testing AS/NZS 4760, section 2 Collection, storage, handling and dispatch | Oral fluid | Handling and dispatch; Sample collection and storage |
| Medico legal drug testing AS/NZS 4760, section 5 Laboratory confirmatory procedures | Oral fluid | 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; Amphetamines; Benzoylecgonine (ecgonine benzoate); Cocaine; Codeine; Diazepam; Methylamphetamine; Morphine; Oxycodone; Phentermine; Pholcodine; Temazepam; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2184
Site No.
2177
Print date
20 Sep 2024
END OF SCOPE